Buy Kemocarb 450mg Carboplatin IP

Kemocarb 450mg (Carboplatin IP) is a chemotherapy medication used for cancer treatment. Available in 450MG/45ML vials, it works by slowing or stopping cancer cell growth. This product is manufactured by Fresenius Kabi Oncology Ltd and stored at ambient temperature.

Strength

450MG/45ML

Pack Size

Storage

Ambient

Manufacturer / TM Owner

FRESENIUS KABI ONCOLOGY LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Kemocarb 450mg is primarily used to treat various types of cancer, including ovarian, lung, and head and neck cancers. It may be prescribed alongside other medications as part of a chemotherapy regimen. Patients often ask, 'what is Kemocarb 450mg used for' to understand its role in cancer care. This medication works systemically to target rapidly dividing cells.

Side Effects

Kemocarb 450mg may cause side effects such as nausea, fatigue, or low blood cell counts. Some patients experience hair thinning or changes in taste. These effects vary by individual and treatment duration. Healthcare providers monitor patients closely during therapy to manage any reactions.

Precautions & Warnings

Kemocarb 450mg should be handled with care by trained medical professionals. It is not for self-administration and requires proper disposal of vials and equipment. Patients should avoid contact with the medication and report any unusual symptoms immediately. Storage at ambient temperature is recommended.

Avoid Interactions

Kemocarb 450mg may interact with other medications, including certain vaccines or drugs affecting bone marrow function. Alcohol and herbal supplements should be used cautiously during treatment. Patients should inform their healthcare provider about all medications they are taking. Some interactions may increase side effects or reduce efficacy.

References

Frequently Asked Questions

Kemocarb 450mg is used to treat various cancers, including ovarian, lung, and head and neck cancers, as part of chemotherapy.

Kemocarb 450mg is administered intravenously by healthcare professionals in a clinical setting.

Common side effects may include nausea, fatigue, low blood cell counts, and hair thinning.

Yes, Kemocarb 450mg should be stored at ambient temperature as directed.

It may interact with certain drugs, so patients should inform their healthcare provider about all medications they are taking.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.